AngioDynamics Inc. [NASDAQ:ANGO] will report earnings after markets close on Thursday, January 7th.
ANGO Earnings Forecast For The Current Quarter
AngioDynamics Inc. [ANGO] is expected to report weak earnings results for the quarter ending on Nov 2020. Consensus estimates give the company expected revenues of $67.35M and an earnings per share of -$0.02 for Nov 2020. Looking further ahead, the company is expected to report revenue of $70.25M at an EPS of -$0.01 for Feb 2021. The estimates represent 5.40% and 764.71% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
ANGO Earnings Estimates For The Current Year
For the financial year, AngioDynamics Inc. [NASDAQ:ANGO] is expected to bring in revenue of $281.66M. The returns are nearly $17.5 million higher than the company’s actual revenue recorded in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at 0.02, lower than that of FY20 by -$0.07. Estimates put this year’s earnings growth at -77.80%, 650.00% for the next, and at an annual 15.00% over the next 5-year period. As for sales, forecasts are for an increase of 6.60% in the current fiscal year and a further 5.40% over the following year.
ANGO Price Performance
On Wall Street, AngioDynamics Inc. [NASDAQ:ANGO] finished Tuesday’s session up 0.58% at $15.53. The stock went up to $15.88 at the same session while its lowest single day price was $15.195. In the last five days, it saw a rise of about 9.75%, AngioDynamics Inc. shares gained by almost 1.30% since the beginning of the year. However, the share price has dropped to as low as -9.92% below its one year high. On 01/04/21, the company shares recorded $15.98, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $14.96. The company’s shares have declined by -8.11% in the past year. The 50-day SMA achieved is $13.21 while the 200-day SMA is $10.84. Volume gained to 0.29 million from 0.25 million in the previous session.
ANGO Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 15.19 level, and in case of violation of this particular level, it will cause more drop to 14.85 level. On the upper level, 16.22 is still the key resistance. The stock may increase to the subsequent resistance at 15.88. The Relative Strength Index (RSI) pinned on the 14-day chart is 68.09, implying a neutral technical stance while the MACD stands at 0.89, meaning price will decrease in the next trading period. Percent R indicator oved to 19.91%, implying bullish price movement. Stochastic %K at 80.76% suggest selling the stock.
Is AngioDynamics Inc. [NASDAQ:ANGO] a Good Buy Right Now?
It should be noted that ANGO technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 88% Buy in the last week and compares with 100% Buy in the past month. Data from AngioDynamics Inc.’s Trend Spotter indicated that the signals were Strengthening. The stock current average is 0.27 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.25 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.27 million shares.
What is the short interest in AngioDynamics Inc.?
Short interest in the AngioDynamics Inc. stock has surged, increasing by 0.4 million shares to total 0.84 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 1.24 million, data from Yahoo Finance shows. The decrease of -46.77% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover moved to short ratio while the shorted shares account for just 3.20% of the overall float for the stock.
AngioDynamics Inc.’s Biggest Shareholders: Who Owns AngioDynamics Inc. [ANGO]?
Filings by BlackRock Fund Advisors showed that the firm now holds a total of 5,808,286 shares or roughly 15.30% of the outstanding ANGO shares. This means their shares have increased by 55,746 from the 5,808,286 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, Victory Capital Management, Inc. updated stake is worth $71,905,705. Details in the latest 13F filings reveal that Dimensional Fund Advisors LP disposed off their -1.49% stake valued at $43,062,739 while The Vanguard Group, Inc. cut theirs at $32,578,048. During the last quarter, Dimensional Fund Advisors LP liquidated -45,687 of its shares in AngioDynamics Inc. while The Vanguard Group, Inc. sold -107,502 shares. The SSgA Funds Management, Inc.’s holdings currently number 1,837,599 shares at $28537912.47. According to the firm’s last 13F report, Northern Trust Investments, Inc. shares in the company at filing stood at 1,184,287 shares, roughly $16,840,561.
What are analyst thoughts on AngioDynamics Inc.?
Looking forward to the AngioDynamics Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for AngioDynamics Inc. stock at $16.00 within the next 12 months, which represents almost 2.94 per cent growth from its previous closing price of $15.53. The highest analysts’ target for AngioDynamics Inc. stock projections is $18.00 and the lowest one is $14.00. Still, 3 analysts sharing their consensus rating for ANGO stock in 2021 agree that it is an Overweight.